[
  {
    "ts": "2026-01-07T02:10:00+00:00",
    "headline": "Best Peptides for Weight Loss 2026: Oral Wegovy Launch Expands GLP-1 Format Options as Telehealth Platforms Compare FDA-Approved vs Compounded Semaglutide Access",
    "summary": "Following Oral Wegovy Introduction, Consumer Analysis Examines Injectable vs Oral Semaglutide Pricing, Compounded Tirzepatide Access Through Direct Meds, and Three-Entity Telehealth Platform StructureHOUSTON, TX, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Medical decisions about prescription weight-management treatments are appropriately made with a qualified clinician who can evaluate individual risks and eligibility.",
    "url": "https://finance.yahoo.com/news/best-peptides-weight-loss-2026-021000107.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "575dbca8-b996-3188-9676-aa0919f8349f",
      "content": {
        "id": "575dbca8-b996-3188-9676-aa0919f8349f",
        "contentType": "STORY",
        "title": "Best Peptides for Weight Loss 2026: Oral Wegovy Launch Expands GLP-1 Format Options as Telehealth Platforms Compare FDA-Approved vs Compounded Semaglutide Access",
        "description": "",
        "summary": "Following Oral Wegovy Introduction, Consumer Analysis Examines Injectable vs Oral Semaglutide Pricing, Compounded Tirzepatide Access Through Direct Meds, and Three-Entity Telehealth Platform StructureHOUSTON, TX, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Medical decisions about prescription weight-management treatments are appropriately made with a qualified clinician who can evaluate individual risks and eligibility.",
        "pubDate": "2026-01-07T02:10:00Z",
        "displayTime": "2026-01-07T02:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/df21957acdd7c42436e3aaedec558622",
          "originalWidth": 160,
          "originalHeight": 37,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xS8T3RYGrDPJRFqfUJN7LQ--~B/aD0zNzt3PTE2MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/df21957acdd7c42436e3aaedec558622.cf.webp",
              "width": 160,
              "height": 37,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/039gIHMOyF50T_.LvM5i0Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/df21957acdd7c42436e3aaedec558622.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/best-peptides-weight-loss-2026-021000107.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/best-peptides-weight-loss-2026-021000107.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T01:50:00+00:00",
    "headline": "Warning: This Skyrocketing Stock Has a Hidden Risk",
    "summary": "Novo Nordisk's new GLP-1 pill highlights the risk that Eli Lilly faces, as investors reward it for being at the forefront of the weight loss market.",
    "url": "https://www.fool.com/investing/2026/01/06/warning-skyrocketing-stock-hidden-risk-lly/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "65266ece-00cb-340b-8630-4a3b1a187036",
      "content": {
        "id": "65266ece-00cb-340b-8630-4a3b1a187036",
        "contentType": "STORY",
        "title": "Warning: This Skyrocketing Stock Has a Hidden Risk",
        "description": "",
        "summary": "Novo Nordisk's new GLP-1 pill highlights the risk that Eli Lilly faces, as investors reward it for being at the forefront of the weight loss market.",
        "pubDate": "2026-01-07T01:50:00Z",
        "displayTime": "2026-01-07T01:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/9e232c91e4847823108a7df0acac4130",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "People in business attire leaving the starting line on a track.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CDRGF1muIS2SuyvzghsAVg--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/9e232c91e4847823108a7df0acac4130.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5jDXQKQhPaRHYHTl3MeuJA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/9e232c91e4847823108a7df0acac4130.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/06/warning-skyrocketing-stock-hidden-risk-lly/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/warning-skyrocketing-stock-hidden-risk-015000651.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]